Your Client Rank:
Loading...
99
Updated 21-Feb-2026
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Ascendis | 34.8% | 0.1% | -20.2% | -21.5% | | | | |
| Lilly | 14.1% | 0.1% | -4.8% | -7.4% | 4.4% | -0.7% | 20.0% | 20.2% |
| Vertex | 10.6% | 0.4% | -2.2% | -5.2% | 3.6% | 3.0% | 12.6% | 12.8% |
| Daiichi | 8.5% | 1.4% | 1.3% | -4.0% | 5.6% | 2.9% | 13.4% | 13.6% |
| Chugai | 7.7% | 1.9% | -5.2% | -3.0% | 0.6% | -2.2% | 11.2% | 11.2% |
| Regeneron | 7.5% | 0.2% | -2.4% | -2.0% | 3.2% | 4.7% | 11.0% | 11.3% |
| Eisai | 7.0% | -1.0% | -2.0% | -5.3% | 9.7% | -1.1% | 16.9% | 18.6% |
| Astra | 6.7% | 0.4% | -2.4% | -2.0% | 3.9% | 1.8% | 11.2% | 11.7% |
| JNJ | 6.2% | 0.3% | -1.1% | -0.5% | 2.9% | 1.0% | 9.0% | 9.3% |
| AbbVie | 6.0% | -0.3% | -2.4% | -9.0% | 6.2% | -2.8% | 13.7% | 13.7% |
| Novo | 5.7% | 0.4% | -1.0% | -2.0% | 1.8% | -0.8% | 6.3% | 7.0% |
| Sanofi | 5.1% | 0.5% | -1.7% | -1.9% | 3.2% | 0.4% | 7.5% | 9.2% |
| Gilead | 4.2% | -0.1% | -0.9% | -4.4% | 2.4% | 1.3% | 7.3% | 7.5% |
| Novartis | 3.9% | 0.0% | -0.1% | -0.1% | 1.2% | 0.1% | 5.0% | 6.0% |
| Shionogi | 3.9% | -0.7% | 0.8% | -2.3% | -6.5% | 1.8% | -1.6% | -1.0% |
| Roche | 3.8% | 0.2% | -1.2% | -0.4% | 2.5% | 1.0% | 7.2% | 7.2% |
| Amgen | 3.2% | 0.0% | 0.1% | -1.3% | 0.5% | 1.9% | 4.7% | 5.2% |
| Merck | 2.4% | -0.1% | -0.4% | 0.2% | 0.3% | 2.9% | 2.3% | 3.1% |
| Bayer | 2.4% | | | | | | 5.9% | 7.4% |
| Teva | 2.3% | 1.1% | -1.4% | 0.1% | 2.0% | 0.7% | 6.6% | 5.8% |
| Takeda | 2.0% | 0.3% | -1.1% | 1.1% | 13.0% | -6.9% | 8.1% | 5.3% |
| Glaxo | 1.3% | -0.2% | 0.5% | 0.3% | 1.1% | 0.9% | 3.8% | -3.7% |
| Biogen | -1.4% | 0.1% | 1.0% | -3.5% | 1.4% | 1.4% | 1.4% | 1.2% |
| Lundbeck | -2.2% | -0.7% | 3.1% | 5.4% | -2.4% | -3.5% | -0.2% | -3.4% |
| Pfizer | -4.1% | -0.4% | 0.8% | 1.7% | -1.2% | 4.0% | -5.2% | -5.8% |
| Bristol | -5.0% | 0.5% | 3.4% | -1.6% | 2.2% | 0.7% | -4.2% | -4.6% |
| Astellas | -5.1% | -0.8% | -3.2% | 3.2% | -2.8% | 0.1% | -7.0% | -7.4% |
| Neurocrine | | | | | | | | |
| EU Major | 4.2% | 0.2% | -0.9% | -0.7% | 2.7% | 0.6% | 7.0% | 8.1% |
| Other EU | 8.9% | 0.1% | -5.6% | -4.6% | 21.1% | -17.6% | 56.2% | |
| US Major | 4.6% | 0.2% | -1.4% | -3.4% | 3.5% | 0.7% | 8.3% | 12.5% |
| US Big Biotech | 4.7% | 0.2% | -1.2% | -2.6% | 2.0% | 2.2% | 7.5% | 8.9% |
| Other US | 2.3% | 1.1% | -1.4% | 0.1% | 2.0% | 0.7% | 6.6% | 5.8% |
| Japanese | 3.4% | 0.5% | -1.1% | -0.9% | 4.3% | -0.7% | 7.2% | 7.1% |
